The latest news from Arcinova
December 14, 2017
Prize-winning performance from Luke
Luke Robinson, an analytical scientist in our CMC team, has won a major national award. Luke, a Biopharmaceutical Science graduate from The University of Sunderland – who joined Arcinova
December 13, 2017
Arcinova expands as new recruits join the CMC team
We have recruited seven new scientists to strengthen our CMC team. The new recruits include Luke Robinson, Ellie Woodhead and Lucy Carruthers, who have joined the department as
October 31, 2017
Arcinova expands as new recruits join Bioanalysis team
Polly Wight, Liam Burns and Jenny Baker have joined Arcinova as bioanalysts and will be responsible for supporting the Bioanalysis team across a range of services, including sample preparation, an
October 30, 2017
Arcinova strengthens API services
Arcinova has made a major investment in its Active Pharmaceutical Ingredient (API) capabilities. We are pleased to announce that we have introduced two new 20-litre GMP vessel streams to o
October 27, 2017
EBF Workshop Presentation, Lisbon
Stuart’s presentation, entitled General Principles of Stability Testing: What Is A Single Source? formed part of the EBF’s Industry input into ICH M10: Experimental data as the cornerstone for
August 31, 2017
Arcinova are now a member of Science Exchange
The Science Exchange is an online collaboration platform designed to enable the outsourcing of research and development services. The Science Exchange is 'the leading marketplace for scientific re
August 31, 2017
Arcinova partakes in The Stephen Carey Fund defibrillator training
The Stephen Carey Fund work with communities and organisations throughout Northumberland to help combat cardiac arrest. The fund was launched in 2013 as attempt to introduce life-saving skills and
July 2, 2017
Arcinova Q2 Newsletter 2017
The Q2 newsletter, reporting updates for each department and the installation of the Uniqsis continuous flow equipment as a means to enhance our capabilities.
June 21, 2017
Arcinova Invests in Uniqsis FlowSyn™ Continuous Flow Reactor
The addition of the Uniqsis FlowSyn™ reactor will enable Arcinova to develop and simplify the scale-up of a challenging API batch process.Discover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.
